Cresco Labs Inc.
CL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 726.35M | 734.82M | 747.27M | 756.06M | 766.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 726.35M | 734.82M | 747.27M | 756.06M | 766.85M |
| Cost of Revenue | 360.10M | 370.67M | 392.28M | 408.52M | 428.30M |
| Gross Profit | 366.26M | 364.15M | 354.99M | 347.54M | 338.55M |
| SG&A Expenses | 221.64M | 226.22M | 239.46M | 258.73M | 282.98M |
| Depreciation & Amortization | 26.29M | 26.53M | 25.69M | 24.54M | 20.58M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 608.03M | 623.42M | 657.43M | 691.79M | 731.86M |
| Operating Income | 118.33M | 111.40M | 89.84M | 64.27M | 35.00M |
| Income Before Tax | -853.00K | -131.37M | -119.95M | -146.90M | -316.58M |
| Income Tax Expenses | 55.21M | 30.45M | 34.14M | 32.95M | 48.76M |
| Earnings from Continuing Operations | -56.06 | -161.81 | -154.10 | -179.85 | -365.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -11.37M | -10.65M | -569.00K | 4.33M | 25.85M |
| Net Income | -67.43M | -172.46M | -154.66M | -175.52M | -339.49M |
| EBIT | 118.33M | 111.40M | 89.84M | 64.27M | 35.00M |
| EBITDA | 183.77M | 177.21M | 154.73M | 126.78M | 91.72M |
| EPS Basic | -0.20 | -0.51 | -0.47 | -0.54 | -1.08 |
| Normalized Basic EPS | -0.03 | -0.04 | 0.05 | 0.02 | 0.03 |
| EPS Diluted | -0.20 | -0.51 | -0.47 | -0.54 | -1.08 |
| Normalized Diluted EPS | -0.03 | -0.04 | 0.05 | 0.02 | 0.03 |
| Average Basic Shares Outstanding | 1.37B | 1.36B | 1.33B | 1.29B | 1.26B |
| Average Diluted Shares Outstanding | 1.37B | 1.36B | 1.33B | 1.29B | 1.26B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.30% | -- | -- | -- | -- |
